Presenilin 1 Gene
Presenilin 1 (PS1 or PSEN1) and presenilin 2 (PS2 or PSEN2) are proteins that span the cell membrane and are primarily expressed in neurons.
Presenilin 1 (PS1 or PSEN1) and presenilin 2 (PS2 or PSEN2) are proteins that span the cell membrane and are primarily expressed in neurons. Presenilin 1 and Presenilin 2 determine gamma-secretase activity, which is responsible for cleaving the amyloid precursor protein (APP). In turn, APP cleavage can produce amyloid-beta, which is the primary component of plaques in the brains of Alzheimer’s disease patients. It follows, that interactions between presenilins and APP are critical to the cause/prevention of Alzheimer’s disease, and presenilins have been consistently shown to associate with the disorder (see, for example a review by Selkoe and Wolfe, 2007).
alzheimer, gene, presenilin, ps1, psen1, cell membrane, cleavage, plaques, proteins, gamma secretase
- ID: 1449
- Source: DNALC.G2C
Related Content
1450. Presenilin 2 Gene
Presenilin 1 (PS1 or PSEN1) and presenilin 2 (PS2 or PSEN2) are proteins that span the cell membrane and are primarily expressed in neurons.
1447. Alzheimer's Disease Candidate Genes
Genes that can cause neurofibrillary tangles and amyloid plaques are strongly associated with Alzheimer's disease.
2135. APP - amyloid clearance and production
Professor Dennis Selkoe compares the amyloid precursor (or parent) protein to a Bic pen. The clasp part seems to be the bad guy, and is part of a network involving presenilin and ApoE4.
1448. APP Gene
Amyloid precursor protein (APP) is expressed in the synapses of neurons and is thought to be responsible for forming and repairing synapses.
799. Beta-amyloid Plaques
Alzheimer's disease is characterized by abnormal plaques and tangles in the brains of patients.
2137. Amyloid plaques - rarely found in childhood
Professor Dennis Selkoe discusses the age at which plaque-forming a-beta can begin to build up. Children with Down syndrome may have these plaques, otherwise childhood instances are rare.
796. New Treatments for Alzheimer's Disease
Researchers reported progress on several potential drug therapies for people with Alzheimer's disease.
1452. Tau Gene (MAPT)
Neurofibrillary tangles are bundles of tau proteins, which mark the tau gene (MAPT) as a strong candidate for Alzheimer’s disease.
794. Background to Alzheimer's Disease
Alzheimer’s disease is a progressive brain disorder that causes a gradual and irreversible loss of higher brain functions, including memory, language skills, and perception of time and space,
2028. Senile plaques and Alzheimer's disease
Professor Kenneth Kosik describes senile plaques, an extracellular collection of a-beta protein. It is one of the hallmarks of Alzheimer's disease.